1. AB0040 Immune modulatory effects of mesenchymal stem cell to mononuclear cells from patients with active adult onset still's disease. (15th June 2017) Authors: Sohn, IW; Jeong, H-J; Ahn, GY; Kim, MJ; Kim, H; Kang, S; Yoo, DH Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0178 Rituximab is effective in the treatment of rheumatoid arthritis regardless of body mass index. (15th June 2017) Authors: Yoo, DH; Park, W; Suh, CH; Shim, SC; Lee, SJ; Bae, YJ; Park, C; Koo, JH Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease. (March 2014) Authors: Jung, K-H; Kim, J-J; Lee, J-S; Park, W; Kim, T-H; Jun, J-B; Yoo, DH Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 2(2014) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0146 Randomised double-blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results. (15th June 2017) Authors: Suh, C-H; Khouri, E Chalouhi El; Miranda, P; Molina, F F Cons; Shesternya, P; Medina-Rodriguez, F; Wiland, P; Jeka, S; Chavez-Corrales, J; Linde, T; Hrycaj, P; Hospodarskyy, I; Abello-Banfi, M; Jaworski, J; Piotrowski, M; Park, W; Shim, SC; Lee, SJ; Lee, SY; Yoo, DH Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗